IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_ncomms16013.html
   My bibliography  Save this article

Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability

Author

Listed:
  • Tohru Takaki

    (Cancer Research UK London Research Institute, Clare Hall Laboratories
    DSB Repair Metabolism Laboratory, The Francis Crick Institute)

  • Marco Montagner

    (Tumour Cell Biology Laboratory, The Francis Crick Institute)

  • Murielle P. Serres

    (Cancer Research UK London Research Institute, Clare Hall Laboratories
    MRC Laboratory for Molecular Cell Biology)

  • Maël Le Berre

    (Institut Curie, PSL Research University)

  • Matt Russell

    (Electron Microscopy Group, The Francis Crick Institute)

  • Lucy Collinson

    (Electron Microscopy Group, The Francis Crick Institute)

  • Karoly Szuhai

    (LUMC)

  • Michael Howell

    (High Throughput Screening Laboratory, The Francis Crick Institute)

  • Simon J. Boulton

    (DSB Repair Metabolism Laboratory, The Francis Crick Institute)

  • Erik Sahai

    (Tumour Cell Biology Laboratory, The Francis Crick Institute)

  • Mark Petronczki

    (Cancer Research UK London Research Institute, Clare Hall Laboratories
    Boehringer Ingelheim RCV GmbH & Co KG)

Abstract

Altered nuclear shape is a defining feature of cancer cells. The mechanisms underlying nuclear dysmorphia in cancer remain poorly understood. Here we identify PPP1R12A and PPP1CB, two subunits of the myosin phosphatase complex that antagonizes actomyosin contractility, as proteins safeguarding nuclear integrity. Loss of PPP1R12A or PPP1CB causes nuclear fragmentation, nuclear envelope rupture, nuclear compartment breakdown and genome instability. Pharmacological or genetic inhibition of actomyosin contractility restores nuclear architecture and genome integrity in cells lacking PPP1R12A or PPP1CB. We detect actin filaments at nuclear envelope rupture sites and define the Rho-ROCK pathway as the driver of nuclear damage. Lamin A protects nuclei from the impact of actomyosin activity. Blocking contractility increases nuclear circularity in cultured cancer cells and suppresses deformations of xenograft nuclei in vivo. We conclude that actomyosin contractility is a major determinant of nuclear shape and that unrestrained contractility causes nuclear dysmorphia, nuclear envelope rupture and genome instability.

Suggested Citation

  • Tohru Takaki & Marco Montagner & Murielle P. Serres & Maël Le Berre & Matt Russell & Lucy Collinson & Karoly Szuhai & Michael Howell & Simon J. Boulton & Erik Sahai & Mark Petronczki, 2017. "Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability," Nature Communications, Nature, vol. 8(1), pages 1-13, December.
  • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms16013
    DOI: 10.1038/ncomms16013
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms16013
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms16013?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms16013. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.